Choi et al. reported that the BRAF mutation in thyroid cancer inhibits NIS expression by upregulating DNMT1, an inducer of promoter methylation in CpG islands (Figure 1A) 123. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.